Adaptive Biotechnologies Corp SEC filings ADPT
Adaptive Biotechnologies Corp has 833 filings in SEC EDGAR's recent list, going back to Dec 28, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 23, 2020 | — |
| CORRESP | Letter to the SEC | Jan 21, 2020 | — |
| CORRESP | Letter to the SEC | Jan 21, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2020 | — |
| DRS | Filing | Jan 9, 2020 | — |
| EFFECT | Filing | Jun 26, 2019 | — |
| CERT | Filing | Jun 26, 2019 | — |
| 8-A12B | Filing | Jun 26, 2019 | — |
| CORRESP | Letter to the SEC | Jun 24, 2019 | — |
| CORRESP | Letter to the SEC | Jun 24, 2019 | — |
| SEC STAFF LETTER | Filing | Jun 19, 2019 | — |
| CORRESP | Letter to the SEC | Jun 17, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2019 | — |
| CORRESP | Letter to the SEC | Jun 4, 2019 | — |
| CORRESP | Letter to the SEC | May 30, 2019 | — |
| SEC STAFF LETTER | Filing | May 23, 2019 | — |
| UPLOAD | Letter from the SEC | May 23, 2019 | — |
| DRSLTR | Filing | May 8, 2019 | — |
| DRS/A | Filing | May 8, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2019 | — |
| DRS | Filing | Mar 29, 2019 | — |
| D | Filing | May 11, 2015 | — |
| D | Filing | Jan 22, 2015 | — |
| D | Filing | Jan 21, 2015 | — |
| D/A | Filing | Aug 4, 2014 | — |
| D | Filing | Apr 15, 2014 | — |
| D | Filing | Jul 12, 2013 | — |
| D | Filing | Jun 21, 2012 | — |
| D | Filing | Jun 2, 2011 | — |
| D | Filing | Dec 28, 2009 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ADPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- WA
- Headquarters
- Seattle, WA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1478320
- Former names
- Adaptive TCR Corp (until Jun 2, 2011)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.